Pharmacotherapy of Anxiety and Repetitive Behaviors in Autism Spectrum Disorders

Propper, Lukáš; Orlik, Herbert

doi:10.1521/capn.2014.19.1.5

Cited by 2 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Relative to medication, CBT is more cost-effective (Roberge, Marchand, Reinharz, Marchand, & Cloutier, 2004) and may show superior long-term effects (Hofmann, Sawyer, Korte, & Smits, 2009). The few studies of the effects of medication treatment for anxiety and depression among adults with ASD have been mixed (Propper & Orlik, 2014; Williams, Wheeler, Silove, & Hazell, 2010). Only two medications (risperidone and aripiprazole) currently have FDA approval for individuals with ASD, both for treating irritability symptoms.…”

mentioning

confidence: 99%

Treatment utilization by adults with autism and co-occurring anxiety or depression

Maddox

Kang-Yi

Brodkin

et al. 2018

Research in Autism Spectrum Disorders

View full text Add to dashboard Cite

Background While a growing body of research suggests that talk therapies can reduce anxiety and depression in adults with autism spectrum disorder (ASD), we know little about what community treatment for these disorders looks like for them. The present study investigated whether treatment utilization differs between adults with and without ASD who have anxiety or depression. Method Using Pennsylvania Medicaid claims data, adults aged 18–65 years diagnosed with ASD and depression or anxiety (n = 268) were matched 1:4 to adults with depression or anxiety disorder without ASD (n = 1,072). Chi-square tests and generalized linear models were used to estimate differences in diagnoses and psychiatric treatment between groups. Results While the proportion of people prescribed benzodiazepine and antidepressants did not differ between groups, the ASD group had more days per month prescribed for all medications. Adults with ASD also were more likely to be prescribed multiple medications concurrently and to use case management. Adults without ASD were more likely to receive talk therapy for anxiety/depression. Among those receiving talk therapy, adults with ASD averaged more individual visits per month. Conclusions Findings suggest that therapists may need more session time for adults with ASD, although it is unclear if this time is dedicated to anxiety or depression treatment. The greater use of psychotropic medications among adults with ASD may suggest unresponsiveness to the talk therapy they receive or greater clinical complexity.

show abstract

mentioning

confidence: 99%